Ocular Therapeutix (OCUL) Return on Sales (2014 - 2026)
Ocular Therapeutix (OCUL) posted quarterly Return on Sales of 0.06% for Q2 2026, down 1.0% year-over-year from 0.06% in Q2 2025, and up 29.4% on a QoQ basis from 0.08% in Q1 2026.
Ocular Therapeutix (OCUL) Return on Sales (2014 - 2026) Analysis & Trends
Ocular Therapeutix has reported Return on Sales for 13 years, with the latest figure at 0.06% in Q2 2026.
- Return on Sales for Q2 2026 came in at 0.06%, down 1.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.06% (down 2.0% YoY), and the FY2025 annual result was 0.1%, down 5.0% from the prior year.
- Return on Sales climbed to 0.06% in Q2 2026, from 0.08% in the prior quarter.
- Over five years, Return on Sales peaked at 0.01% in Q4 2023 and troughed at 0.08% in Q1 2026.
- A 5-year average of 0.03% and a median of 0.03% in 2024 frame the typical range for Return on Sales.
- The widest annual swing landed in 2022, when Return on Sales grew 2 bps; it then slipped 3 bps in 2025.
- A 5-year view of Return on Sales shows it stood at 0.01% in 2022, then increased by 13 bps to 0.01% in 2023, then tumbled by 152 bps to 0.03% in 2024, then plunged by 72 bps to 0.05% in 2025, then decreased by 20 bps to 0.06% in 2026.
- Per Business Quant data, the three most recent Return on Sales figures were 0.06% in Q2 2026, 0.08% in Q1 2026, and 0.05% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Ocular Therapeutix | 2.20 Bn | 2.20 Bn | 11.46 Mn | -0.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.06% |
| Mar 31, 2026 | -0.08% |
| Dec 31, 2025 | -0.05% |
| Sep 30, 2025 | -0.05% |
| Jun 30, 2025 | -0.05% |
| Mar 31, 2025 | -0.06% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.03% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.03% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.02% |